AAAAAA

   
Results: 1-8 |
Results: 8
1,2,5-OXADIAZOLE N-OXIDE DERIVATIVES AS HYPOXIA-SELECTIVE CYTOTOXINS - STRUCTURE-ACTIVITY-RELATIONSHIPS
Authors: MONGE A DECERAIN AL EZPELETA O CERECETTO H DIAS E DIMAIO R GONZALEZ M ONETTO S RISSO M SEOANE G ZINOLA F OLEAAZAR C
Citation: A. Monge et al., 1,2,5-OXADIAZOLE N-OXIDE DERIVATIVES AS HYPOXIA-SELECTIVE CYTOTOXINS - STRUCTURE-ACTIVITY-RELATIONSHIPS, Die Pharmazie, 53(10), 1998, pp. 698-702
FLUDARABINE, ARA-C AND ANTRACYCLINE - A SHORT, INTENSIVE AND TOLERABLE INDUCTION THERAPY OF DE-NOVO ACUTE MYELOID-LEUKEMIA
Authors: CLAVIO M CERRI R PIERRI I BALLEARI E GATTO S BELTRAMI G MASOUDI B CAVALIERE M RISSO M PIETRASANTA D QUINTINO S DAMASIO E GHIO R GOBBI M
Citation: M. Clavio et al., FLUDARABINE, ARA-C AND ANTRACYCLINE - A SHORT, INTENSIVE AND TOLERABLE INDUCTION THERAPY OF DE-NOVO ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 220-221
COST OF DE-NOVO ACUTE MYELOID-LEUKEMIA INDUCTION, THERAPY - COMPARISON BETWEEN EORTC-GIMEMA AML10 AND FLANG REGIMENS
Authors: GOBBI M CLAVIO M MASOUDI B QUINTINO S PIERRI I CERRI R CANEPA L MUNER P RAINERO S RISSO M CAVALIERE M BELTRAMI G DAMASIO E
Citation: M. Gobbi et al., COST OF DE-NOVO ACUTE MYELOID-LEUKEMIA INDUCTION, THERAPY - COMPARISON BETWEEN EORTC-GIMEMA AML10 AND FLANG REGIMENS, British Journal of Haematology, 102(1), 1998, pp. 227-227
THE ROLE OF FLUDARABINE COMBINATIONS IN DE-NOVO ACUTE MYELOID-LEUKEMIA THERAPY - ANALYSIS OF 50 PATIENTS
Authors: GOBBI M CLAVIO M MIGLINO M QUINTINO S CERRI R RISSO M PIETRASANTA D PIERRI I BALLERINI F CAVALIERE M BELTRAMI G VALLEBELLA E CELESTI L CANEPA L SPRIANO M DAMASIO E
Citation: M. Gobbi et al., THE ROLE OF FLUDARABINE COMBINATIONS IN DE-NOVO ACUTE MYELOID-LEUKEMIA THERAPY - ANALYSIS OF 50 PATIENTS, Blood, 90(10), 1997, pp. 3825-3825
CLINICAL-APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS
Authors: CARRARA P CLAVIO M PIERRI I CANEPA L MIGLINO M CELESTI L RISSO M GOBBI M
Citation: P. Carrara et al., CLINICAL-APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS, FCI. Fundamental and clinical immunology, 2(2), 1994, pp. 107-111
INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA
Authors: TURA S BACCARANI M ZUFFA E RUSSO D ZACCARIA A FIACCHINI M TESTONI N ZAMAGNI MD MARTINELLI G DAMIANI D MICHIELI M FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C ALIMENA G MANDELLI F LEONI P DANIELI G NOSARI A DECATALDO F MAJOLINO I CARONIA F LIBERATI AM GRIGNANI F TABILIO A MARTELLI M PAOLINO F RESEGOTTI L DITUCCI A BROCCIA G LEONI F CIOLLI S LUCIANO L ROTOLI B PERRICONE R CAJOZZO A MONTUORO A DELAURENZI A VOLPE E DEMILIO A BATTISTA R CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL LOMBARDO M TORLONTANO G LANDOLFI R LEONE G DELFINI C SPARAVENTI G PAPINESCHI F SPREMOLLA G RISSO M MARMONT AM DINI D DIPRISCO U MANGONI L RIZZOLI V GIRINO M ASCARI E BODENIZZA CA CAROTENUTO M DIFRANCESCO A QUAGLINO D NARDELLI S CICCONE F MIRAGLIA E DEBIASE R GALLO E PILERI A RAMBALDI A BARBUI T MORANDI S BIANCHINI E DEROSA C CIMINO R RONCA F NOBILE F CANTONETTI M PAPA G GALLAMINI A BUFFA F MUSOLINO C SQUADRITO G CAPALDI A GIOVANNELLI E PINOTTI G VENCO A ZAGONEL V PINTO A GENTILINI I COSER P GUGLIELMO P CACCIOLA E PIZZUTI M RICCIUTI F FANIN R CRISCUOLO D MONTEFUSCO E
Citation: S. Tura et al., INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA, The New England journal of medicine, 330(12), 1994, pp. 820-825
WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT
Authors: ZACCARIA A MARTINELLI G BUZZI M FARABEGOLI P SAGLIO G GUERRASIO A BERNABEI PA SANTINI V PELLICCI PG MENCARELLI A COCO FL DIVERIO D RAMBALDI A SANTORO A TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: A. Zaccaria et al., WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT, Leukemia & lymphoma, 11, 1993, pp. 81-89
TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE
Authors: TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S CICCONE F GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: S. Tura et al., TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 11, 1993, pp. 153-157
Risultati: 1-8 |